Articles by Disease (Leukaemia)

Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets

Journal: Current Pharmaceutical Design
Volume: 13
Page: 3400-3416
Author(s): Haruyo Ichikawa, Yutaka Nakamura, Yoshiki Kashiwada and Bharat B. Aggarwal

Novel Marine-Derived Anti-Cancer Agents

Journal: Current Pharmaceutical Design
Volume: 13
Page: 3417-3426
Author(s): Thomas E. Adrian

Contrast Enhanced Sonography for Diagnosis of (Peri-) Splenic Pathology

Journal: Current Medical Imaging
Volume: 3
Page: 283-293
Author(s): Christian Gorg and Till Bert

The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action

Journal: Current Genomics
Volume: 8
Page: 453-465
Author(s): M. J. Simmonds and S. C.L. Gough

Nutrition in Infancy

Journal: Current Pediatric Reviews
Volume: 3
Page: 293-300
Author(s): Hania Szajewska and Andrea Horvath

Voltage-Gated Ion Channels, New Targets in Anti-Cancer Research

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2
Page: 189-202
Author(s): Le Guennec Jean-Yves, Ouadid-Ahidouch Halima, Soriani Olivier, Besson Pierre, Ahidouch Ahmed and Vandier Christophe

Potassium Channels are a New Target Field in Anticancer Drug Design

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2
Page: 212-223
Author(s): Nuria Villalonga, Joan C. Ferrere, Josep M. Argiles, Enric Condom and Antonio Felipe

To Be, or Not To Be: That is the Question-Lineage Commitment in Hematopoiesis

Journal: Current Immunology Reviews (Discontinued)
Volume: 3
Page: 258-268
Author(s): Motonari Kondo and Chia-Lin Hsu

Targeting the Human Thioredoxin System by Diverse Strategies to Treat Cancer and Other Pathologies

Journal: Recent Patents on DNA & Gene Sequences
Volume: 1
Page: 164-175
Author(s): Kathryn F. Tonissen

Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity

Journal: Current Pharmaceutical Design
Volume: 13
Page: 3020-3037
Author(s): P. McCaffery and C. Simons